AGEN stays in channelShorts have lost control and AGEN stays in up trend channel
11 million short shares will have to cover at some point.
AGEN trade ideas
AGEN LongMarket maker is working on keeping the stock in the channel.
Biotec is hot now .
Stock story is good.
MA indicator applied to Agenus Inc. (AGEN) ChartMoving Average indicator is applied to the Agenus Inc. (AGEN) chart. We can see the indicator acting as support line (green arrows), confirming the uptrend of chart, and also acting as resistance line (red arrows), confirming downtrend. When the chart cross the MA line, there is a change in trend.
Agenus Inc. (AGEN) Double Top PatternAGENUS INC. (AGEN), Temporality 1M
An uptrend line is shown, followed by a double top, with two succesive peaks at the same resistence level (dotted short line), with a change in trend. A pullback is noticed after the pattern, but it doesn´t break the support level of pattern (large dotted line).
Volume is lighter on second peak, with a disminution or decrease when trend changes to a downtrend.
AGENI always wish the best for researching companies. But I dunno if I would trade this now. Anyway I love watching charts, so I ll keep an eye on this. Curious to see if it will go lower
AGEN: at old time support! Be a Lynch!Is it going to bounce and go 10 bagger?
Thanks Mr. Peter Lynch.
This is an opinion... don't trade without due diligence.
AGENLearning Fib. levels (entry levels): Fib. proposed this entry (4.55) on 29.04.18, I woulda proposed 3.70
$AGEN Symmetrical Triangle (Breakout)?Lil symmetrical triangle on the weekly. Looking for the breakout above $4.25 ($4.50-$4.75 to be safe). 50SMA crossover 200SMA would fit nicely for a confirmed breakout.
Agenus OpportunityLooking for a buy opportunity in this. Right now I am not in it.
In a down trend here.... lets see how low it goes.
Support and Resistance at $4.23?
WAIT for the pullback, then place your positionsAs we see, the price has been going up, falling back, going up, falling back, going up and now its time to fall back. Once we see how the price falls a little, we need to keep an eye on this one!
I do think the price will go back to around 5-5.10 (we can see it always dropped to somewhere around the last high, just stood slightly above it) and then run up again. I will take only one swing for now, and then see how price continues.
I am not really concerned, since we are in an uptrend, and after the pullback, the trend should continue.
Good luck and good profits to you!
keep it on the watchlistthis one right here will consolidate a bit before the next breakout.
The EAM 200 says its a long position, the uptrend looks stabile, I think we will see a pullback to the support, or even the support below and thats my entry signal.
If you look at it in the higher timeframes, you can see there was a trend reversal wit two big cups net to each other. Thats one more reason for me to believe the uptrend will continue.
For now, its only on my watchlist.
AGEN - Breakout momentum Long from $4.69 AGEN is breaking through a lot os label of resistance. In longer therm its been declining from $10 & now getting some strength, and money flow is very strong now.
It has huge insider buying from another Biotechnology company. We think it has very good upside potential.
* Trade Criteria *
Date First Found- July 17, 2017
Pattern/Why- Flag formation momentum long
Entry Target Criteria- Break of $4.69
Exit Target Criteria- Momentum
Stop Loss Criteria- $4.07
Please check back for Trade updates. (Note: Trade update is little delayed here.)
AEGN COVERED CALLThis little fella popped up on my radar earlier today as having high implied volatility, so I pretty much blindly put on the covered call then and there, buying 100 shares a 6.24 and selling the Sept 16th 7 put for a 5.77 debit (which will be my cost basis in the shares).
The max profit is $123 with a ROC of about 21.3% (assuming a call away at 7).
>6.31 potencial patrón de continuación el precio debe mantenerse por encima de su EMA21 para continuar con potencial movimiento a la alza
How to make 80% return in three month with AgenAgenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the bodys immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a heat shock protein-based autologous vaccine, which has completed Phase II clinical trials for the treatment of glioblastoma; and QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles.The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
